Free Trial

California State Teachers Retirement System Grows Stock Holdings in Amrize Ltd $AMRZ

Amrize logo with Materials background
Image from MarketBeat Media, LLC.

California State Teachers Retirement System raised its holdings in Amrize Ltd (NYSE:AMRZ - Free Report) by 4.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 571,723 shares of the company's stock after purchasing an additional 22,117 shares during the quarter. California State Teachers Retirement System owned 0.10% of Amrize worth $30,472,836 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in AMRZ. MCF Advisors LLC bought a new stake in shares of Amrize during the 4th quarter worth about $27,000. Basepoint Wealth LLC bought a new position in shares of Amrize during the 4th quarter valued at about $33,000. Continuum Advisory LLC bought a new stake in Amrize in the second quarter valued at approximately $62,000. Oslo Pensjonsforsikring AS acquired a new position in Amrize in the first quarter valued at about $133,000. Finally, Caldwell Sutter Capital Inc. grew its stake in shares of Amrize by 11.5% in the first quarter. Caldwell Sutter Capital Inc. now owns 2,675 shares of the company's stock worth $150,000 after purchasing an additional 275 shares during the last quarter.

Analyst Upgrades and Downgrades

Several research analysts have commented on AMRZ shares. Morgan Stanley set a $63.00 price target on shares of Amrize and gave the company an "overweight" rating in a report on Monday, June 22nd. Stephens reduced their price target on Amrize from $65.00 to $54.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 12th. Wells Fargo & Company reissued an "equal weight" rating and issued a $44.00 price objective (down from $55.00) on shares of Amrize in a report on Wednesday, September 9th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating on shares of Amrize in a report on Friday, June 26th. Finally, DA Davidson assumed coverage on Amrize in a research note on Monday, August 24th. They issued a "neutral" rating and a $50.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, eight have issued a Hold rating and four have issued a Sell rating to the company's stock. Based on data from MarketBeat, Amrize currently has a consensus rating of "Hold" and a consensus target price of $55.50.

View Our Latest Stock Report on AMRZ

Amrize Price Performance

Shares of AMRZ stock traded down $0.09 during trading on Tuesday, hitting $39.34. The company had a trading volume of 2,840,949 shares, compared to its average volume of 3,329,954. The stock's 50-day moving average price is $46.94 and its 200 day moving average price is $52.27. Amrize Ltd has a one year low of $39.01 and a one year high of $65.94. The firm has a market capitalization of $21.76 billion, a P/E ratio of 18.14, a price-to-earnings-growth ratio of 1.20 and a beta of 0.04. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.73 and a current ratio of 1.10.

Amrize (NYSE:AMRZ - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing analysts' consensus estimates of $0.92 by ($0.04). The company had revenue of $3.49 billion for the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.22%. Equities analysts expect that Amrize Ltd will post 2.67 EPS for the current fiscal year.

Amrize Announces Dividend

The business also recently announced a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were paid a $0.11 dividend. The ex-dividend date was Tuesday, August 18th. Amrize's dividend payout ratio is presently 20.28%.

Insider Activity at Amrize

In other news, Director Jacques Sanche acquired 4,150 shares of the firm's stock in a transaction on Wednesday, August 26th. The stock was bought at an average cost of $45.02 per share, with a total value of $186,833.00. Following the transaction, the director directly owned 9,766 shares in the company, valued at approximately $439,665.32. This represents a 73.90% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Jan Jenisch purchased 4,000 shares of the company's stock in a transaction on Wednesday, September 2nd. The stock was bought at an average cost of $42.50 per share, for a total transaction of $170,000.00. Following the acquisition, the chief executive officer directly owned 519,000 shares of the company's stock, valued at $22,057,500. This represents a 0.78% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 48,983 shares of company stock worth $2,158,755 over the last 90 days. Corporate insiders own 0.54% of the company's stock.

Amrize Company Profile

(Free Report)

Amrize is a North American building materials and solutions company formed through the separation of Holcim's North American business. The company began trading publicly on the New York Stock Exchange in 2025 under the symbol AMRZ.

Amrize supplies essential construction materials, including cement, aggregates, ready-mix concrete and asphalt. It also provides a range of building products and solutions used in residential, commercial and infrastructure construction, including concrete products, roofing systems and other materials designed to support building and construction projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution operations and local businesses.

Recommended Stories

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amrize Right Now?

Before you consider Amrize, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.

While Amrize currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines